Kentucky Trust Company’s AbbVie ABBV Stock Holding History

Kentucky Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Sell	5,369 -1,220	-19%	-$262K	0.65%	45
2026 Q1	$1.43M	Sell	6,589 -51	-0.8%	-$11.3K	0.75%	43
2025 Q4	$1.52M	Sell	6,640 -199	-3%	-$45.3K	0.8%	43
2025 Q3	$1.58M	Hold	6,839	–	–	0.86%	35
2025 Q2	$1.27M	Sell	6,839 -200	-3%	-$37.2K	0.73%	44
2025 Q1	$1.47M	Sell	7,039 -50	-0.7%	-$9.72K	0.88%	40
2024 Q4	$1.26M	Buy	+7,089	New	+$1.3M	0.74%	41

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Kentucky Trust Company's ABBV Position: Q2 2026 in Review

Kentucky Trust Company reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $262K and leaving 5,369 shares worth $1.35M. The position accounts for 0.65% of the portfolio, ranked #45.

Kentucky Trust Company first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.58M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kentucky Trust Company held 5,369 shares of AbbVie worth $1.35M as of Q2 2026.
Kentucky Trust Company sold 1,220 AbbVie shares in Q2 2026, an estimated $262K.
AbbVie made up 0.65% of Kentucky Trust Company's portfolio in Q2 2026, its #45 holding.
Kentucky Trust Company first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Kentucky Trust Company's AbbVie position peaked at $1.58M in Q3 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kentucky Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.